One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Aurinia Pharmaceuticals now clears that threshold, with a jump from 79 to 83 Tuesday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
This proprietary rating identifies market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks matches up against other publicly traded companies.
Decades of market research shows that the best-performing stocks tend to have an RS Rating of above 80 in the early stages of their moves.
Looking For Winning Stocks? Try This Simple Routine
While the stock is lower priced than usual for CANSLIM investing, it does trade with a large daily volume. Aurinia Pharmaceuticals is currently working on a consolidation with a 12.13 buy point. See if it can continue moving higher and break out in volume at least 40% above average.
AUPH Earnings
The company reported 0% earnings growth in the latest quarterly report, while sales growth came in at 59%. The company is expected to report its latest results on or around Aug. 9.
Aurinia Pharmaceuticals earns the No. 22 rank among its peers in the Medical-Biomed/Biotech industry group. Arcturus Therapeutics and Vertex Pharmaceuticals are also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
